Nucleo Longevity

Ergothioneine

ergothioneine · EGT

A mushroom-derived antioxidant proposed as a possible 'longevity vitamin'.

TypeSupplement / dietary

The grade answers: What does the human evidence support for: Cellular antioxidant / "longevity vitamin"?

Grade

C

Limited

The grade rates evidence quality — it is not advice to take or buy.

Class
Amino acid antioxidant
Primary use
Cellular antioxidant / "longevity vitamin"
Evidence strength
low
Last reviewed
2026-07-01

Bottom line

Genuinely interesting: the body has a dedicated transporter for it, and lower blood levels track with worse aging outcomes. But that's association — no trial yet shows that taking it changes anything.

What the evidence says

Ergothioneine is unusual because human cells express a specific transporter (OCTN1) that concentrates it in tissues under oxidative stress — a strong hint the body values it, which is why some researchers call it a candidate 'longevity vitamin'. Observational studies link lower blood ergothioneine to higher cardiovascular and mortality risk and cognitive decline. What's missing is interventional proof: no randomized trial has shown that supplementing it improves outcomes. Grade C: compelling biology and epidemiology, zero outcome trials.

Key studies

  1. [1]

    Ergothioneine blood levels and mortality/cardiometabolic risk · observational

    Lower levels associated with worse outcomes — not causal.

    Open on PubMed
  2. [2]

    Ergothioneine as a longevity vitamin (review) · review

    Argues the case from transporter biology and epidemiology.

    Open on PubMed
  3. [3]

    Ergothioneine and cognitive aging · observational

    Associations with cognition; interventional data absent.

    Open on PubMed
See all studies on PubMed

Mechanism

A potent, stable antioxidant selectively accumulated by cells via the OCTN1 transporter, concentrating in mitochondria and tissues exposed to oxidative stress; dietary sources are chiefly mushrooms.

Safety

Appears very safe in the limited human data, with high tolerability; long-term supplementation safety is not yet well characterised.

Dosage context

Dietary intake varies with mushroom consumption; supplement trials are few and doses not standardised. Because the evidence is associational, an 'optimal' dose is undefined.

Examples of application

  • Obtained mainly from mushrooms in the diet.
  • Supplement doses aren't standardised, since evidence is associational.
  • A 'watch this space' longevity candidate, not a proven one.

From the field

Ergothioneine is the most interesting molecule here with the least interventional proof: a dedicated transporter and strong associations, but nobody has yet shown that a pill helps. Grade C, and one of the more honest 'watch this space' entries.

Related molecules